Ocugen (OCGN)
(Delayed Data from NSDQ)
$1.28 USD
+0.10 (8.47%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $1.27 -0.01 (-0.78%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Balance Sheet
Fiscal Year End for Ocugen, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 39 | 91 | 95 | 24 | 7 |
Receivables | 0 | 0 | 0 | 0 | 0 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 4 | 8 | 8 | 2 | 8 |
Total Current Assets | 43 | 98 | 103 | 26 | 16 |
Net Property & Equipment | 17 | 6 | 1 | 1 | 0 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 4 | 4 | 2 | 1 | 1 |
Total Assets | 65 | 109 | 106 | 27 | 17 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 3 | 8 | 2 | 0 | 2 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 13 | 10 | 4 | 3 | 2 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 17 | 18 | 7 | 4 | 5 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 3 | 2 | 2 | 2 | 1 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 1 | 0 | 0 | 0 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 24 | 25 | 10 | 6 | 6 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 3 | 2 | 2 | 2 | 1 |
Capital Surplus | 324 | 295 | 226 | 93 | 62 |
Retained Earnings | -286 | -213 | -132 | -73 | -51 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 41 | 84 | 96 | 22 | 11 |
Total Liabilities & Shareholder's Equity | 65 | 109 | 106 | 27 | 17 |
Total Common Equity | 41 | 84 | 96 | 22 | 11 |
Shares Outstanding | 256.50 | 218.80 | 199.10 | 162.00 | 52.60 |
Book Value Per Share | 0.16 | 0.38 | 0.48 | 0.13 | 0.21 |
Fiscal Year End for Ocugen, Inc falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 39 | 53 | 71 | 77 |
Receivables | NA | 0 | 0 | 0 | 0 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 0 | 0 | 0 | 0 |
Other Current Assets | NA | 4 | 3 | 3 | 8 |
Total Current Assets | NA | 43 | 57 | 73 | 84 |
Net Property & Equipment | NA | 17 | 14 | 12 | 8 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 0 | 0 | 0 | 0 |
Deposits & Other Assets | NA | 4 | 4 | 4 | 4 |
Total Assets | NA | 65 | 75 | 89 | 96 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 3 | 3 | 4 | 8 |
Current Portion Long-Term Debt | NA | 0 | 1 | 1 | 1 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 13 | 6 | 8 | 6 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 0 | 0 | 0 | 0 |
Total Current Liabilities | NA | 17 | 11 | 13 | 16 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 3 | 2 | 1 | 1 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 1 | 0 | 0 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 24 | 16 | 19 | 21 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 3 | 3 | 3 | 2 |
Capital Surplus | NA | 324 | 322 | 320 | 303 |
Retained Earnings | NA | -286 | -267 | -252 | -230 |
Other Equity | NA | 0 | 0 | 0 | 0 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 41 | 58 | 70 | 76 |
Total Liabilities & Shareholder's Equity | NA | 65 | 75 | 89 | 96 |
Total Common Equity | 0 | 41 | 58 | 70 | 76 |
Shares Outstanding | 257.30 | 256.50 | 256.40 | 226.40 | 226.40 |
Book Value Per Share | 0.00 | 0.16 | 0.23 | 0.31 | 0.33 |